Free Trial
LON:SAR

Sareum (SAR) Share Price, News & Analysis

Sareum logo
GBX 16.95 -0.05 (-0.29%)
As of 08/1/2025 12:10 PM Eastern

About Sareum Stock (LON:SAR)

Key Stats

Today's Range
16.40
17.14
50-Day Range
13.66
20.65
52-Week Range
11
32
Volume
214,811 shs
Average Volume
412,419 shs
Market Capitalization
£21.18 million
P/E Ratio
N/A
Dividend Yield
1.10%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sareum and its competitors with MarketBeat's FREE daily newsletter.

SAR Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Sareum Holdings Refocuses Strategy After SRA737 Licensing Termination
See More Headlines

SAR Stock Analysis - Frequently Asked Questions

Sareum's stock was trading at GBX 24.60 at the beginning of the year. Since then, SAR shares have decreased by 31.1% and is now trading at GBX 16.95.

Sareum Holdings plc (LON:SAR) released its earnings results on Tuesday, March, 25th. The company reported ($0.90) EPS for the quarter.

Shares of SAR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sareum investors own include ReNeuron Group (RENE), ValiRx (VAL), Sierra Oncology (SRRA), Egdon Resources (EDR), Collagen Solutions plc (COS.L) (COS), Gulf Keystone Petroleum (GKP) and Summit Therapeutics (SMMT).

Company Calendar

Last Earnings
3/25/2025
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Financial Services
Current Symbol
LON:SAR
CIK
N/A
Fax
N/A
Employees
3,211
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (4.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£5.28 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-270.25%
Return on Assets
-113.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.22
Quick Ratio
10.37

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 1.50 per share
Price / Cash Flow
11.32
Book Value
GBX 2.61 per share
Price / Book
6.49

Miscellaneous

Outstanding Shares
124,928,001
Free Float
N/A
Market Cap
£21.18 million
Optionable
Not Optionable
Beta
-1.08
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:SAR) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners